Interferon

MS Patients May Soon Benefit from a New Generation of Oral Drugs

mksmith — Wed, 02 Sep 2009 11:43:46 -0500

Greystone Associates Assesses the Potential and Prospects for Pipeline Candidates Targeting Multiple Sclerosis and their Probable Impact on Existing Treatments

New mechanism regulates type I interferon production in white blood cells

harminka — Tue, 13 Jan 2009 01:42:44 -0600

A study from a team of researchers led by Dr. Andrew P. Makrigiannis, Director of the Molecular Immunology Research Unit at the IRCM, has identified a new mechanism regulating interferon production.

Drugs Based on Immune Factors Set to Double in Value by 2011

mksmith — Mon, 24 Mar 2008 11:48:20 -0500

Greystone Associates Report Analyzes Clinical, Regulatory and Therapeutic Factors Driving Growth of Powerful New Drugs Based on the Human Immune Response

Different factors affect success of interferon treatment for hepatitis C

harminka — Mon, 02 Jul 2007 10:35:24 -0500

A new study on predicting outcomes of standard treatment for hepatitis C virus (HCV) infection found that a number of factors impacted responses, including the form of the interferon given. However, for some genotypes of the disease, few of these factors play a role.

Interferon-treated hepatitis C patients likely to experience retinopathy

harminka — Wed, 03 Jan 2007 12:45:59 -0600